These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 24560870)

  • 21. Host-microbiota interaction in intestinal stem cell homeostasis.
    Wu H; Mu C; Xu L; Yu K; Shen L; Zhu W
    Gut Microbes; 2024; 16(1):2353399. PubMed ID: 38757687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders.
    Macchione IG; Lopetuso LR; Ianiro G; Napoli M; Gibiino G; Rizzatti G; Petito V; Gasbarrini A; Scaldaferri F
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8075-8083. PubMed ID: 31599433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of bile acids in the gut in health and disease.
    Boesjes M; Brufau G
    Curr Med Chem; 2014; 21(24):2822-9. PubMed ID: 24606522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention.
    Jones ML; Martoni CJ; Ganopolsky JG; Labbé A; Prakash S
    Expert Opin Biol Ther; 2014 Apr; 14(4):467-82. PubMed ID: 24479734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular interactions between the intestinal microbiota and the host.
    Hertli S; Zimmermann P
    Mol Microbiol; 2022 Jun; 117(6):1297-1307. PubMed ID: 35403275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary metabolism, the gut microbiome, and heart failure.
    Tang WHW; Li DY; Hazen SL
    Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of Ussing chambers for determining the impact of microbes and probiotics on intestinal ion transport.
    Lomasney KW; Hyland NP
    Can J Physiol Pharmacol; 2013 Sep; 91(9):663-70. PubMed ID: 23984904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional interactions between the gut microbiota and host metabolism.
    Tremaroli V; Bäckhed F
    Nature; 2012 Sep; 489(7415):242-9. PubMed ID: 22972297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity.
    Vrieze A; Out C; Fuentes S; Jonker L; Reuling I; Kootte RS; van Nood E; Holleman F; Knaapen M; Romijn JA; Soeters MR; Blaak EE; Dallinga-Thie GM; Reijnders D; Ackermans MT; Serlie MJ; Knop FK; Holst JJ; van der Ley C; Kema IP; Zoetendal EG; de Vos WM; Hoekstra JB; Stroes ES; Groen AK; Nieuwdorp M
    J Hepatol; 2014 Apr; 60(4):824-31. PubMed ID: 24316517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis.
    Tojo R; Suárez A; Clemente MG; de los Reyes-Gavilán CG; Margolles A; Gueimonde M; Ruas-Madiedo P
    World J Gastroenterol; 2014 Nov; 20(41):15163-76. PubMed ID: 25386066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
    Sittipo P; Shim JW; Lee YK
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial regulation of organismal energy homeostasis.
    Cani PD; Van Hul M; Lefort C; Depommier C; Rastelli M; Everard A
    Nat Metab; 2019 Jan; 1(1):34-46. PubMed ID: 32694818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expanding role of gut microbiota in lipid metabolism.
    Ghazalpour A; Cespedes I; Bennett BJ; Allayee H
    Curr Opin Lipidol; 2016 Apr; 27(2):141-7. PubMed ID: 26855231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism.
    Golubeva AV; Joyce SA; Moloney G; Burokas A; Sherwin E; Arboleya S; Flynn I; Khochanskiy D; Moya-Pérez A; Peterson V; Rea K; Murphy K; Makarova O; Buravkov S; Hyland NP; Stanton C; Clarke G; Gahan CGM; Dinan TG; Cryan JF
    EBioMedicine; 2017 Oct; 24():166-178. PubMed ID: 28965876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bile acids and the gut microbiome.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Curr Opin Gastroenterol; 2014 May; 30(3):332-8. PubMed ID: 24625896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of NMR-based metabolomics to the study of gut microbiota in obesity.
    Calvani R; Brasili E; Praticò G; Sciubba F; Roselli M; Finamore A; Marini F; Marzetti E; Miccheli A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S5-7. PubMed ID: 25291128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probiotics: Interaction with gut microbiome and antiobesity potential.
    Arora T; Singh S; Sharma RK
    Nutrition; 2013 Apr; 29(4):591-6. PubMed ID: 23287068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.